WallSt.net Airing Exclusive Audio Interviews With CBAI, GEECF, AEMD and ASTM

WallSt.net Airing Exclusive Audio Interviews With CBAI, GEECF,
AEMD and ASTM 


NEW YORK, April 18  /PRNewswire/ -- Matt Schissler, Chairman and CEO of Cord
Blood America, Inc. (OTC:CBAI) (BULLETIN BOARD: CBAI)  recently granted Wall
Street Network an exclusive audio interview profiling the company.  Interview
highlights include discussions on the following topics:

   -- 167 percent revenue growth in 2004 over 2003
   -- umbilical cord blood stem cell preservation and storage industry
      growth
   -- keeping pace with industry growth
   -- management bios
   -- competitive edge
   -- mergers and acquisitions strategy
   -- upcoming milestones



To hear the interview in its entirety and to read an in-depth report on the
company, visit http://wallst.net/superstock/CBAI/cbai.html

Christopher McCormack, President and CEO of Global Environmental Energy Corp.
(OTC:GEECF) (BULLETIN BOARD: GEECF)  recently granted Wall Street Network an
exclusive audio interview profiling the company.  Interview highlights include
discussions on the following topics:

   -- recent agreement with Quickflow S.A.
   -- intellectual property
   -- recent sales
   -- capitalization
   -- management bios
   -- upcoming milestones



Jim Joyce, Chairman, President and CEO of Aethlon Medical, Inc. (OTC:AEMD)
(BULLETIN BOARD: AEMD)  recently granted Wall Street Network an exclusive audio
interview profiling the company.  Interview highlights include discussions on
the following topics:

   -- Feedback from the National Aids Conference
   -- Hemopurifier(TM) technology, and its effectiveness with drug resistant
      HIV and Hepatitis C patients
   -- HIV and Hepatitis C trials in India
   -- Financial position
   -- Management bios
   -- Upcoming clinical milestones



Douglas Armstrong, PhD, Chairman and CEO of Aastrom Biosciences, Inc.
(NASDAQ:ASTM) recently granted Wall Street Network an exclusive audio interview
profiling the company. Interview highlights include discussions on the
following topics:

   -- recent expansion of clinical trials
   -- financial position
   -- competitive edge in the cell-therapy arena
   -- an update on European clinical trails
   -- timelines for IND submission
   -- upcoming clinical milestones



To hear the interviews in their entirety, visit http://www.wallst.net/.  The
interviews can be accessed by locating the respective company's ticker symbol
under the exchange on which it trades on the left hand column of the homepage,
or by entering the respective company's ticker symbol in the Audio Search
window.

About Wall Street Network

Wall Street Network is owned and licensed by Wall Street Direct, Inc.  All
material herein was prepared by Digital Wall Street, Inc., a multimedia
provider of original, insightful commentary and news from North America's
leading publicly traded companies giving a direct link to the management of
today's fastest-growing companies through encompassing executive interviews and
sector seminars. The company provides a free service to consumers, and a paid,
premium monthly subscription to its members.  Digital Wall Street Inc. has
received five hundred thousand restricted shares from the company for press and
advertising services, and is expecting to receive an additional five hundred
thousand restricted shares from the company for press and advertising services
for CBAI. Digital Wall Street, Inc. has received three thousand dollars from a
third party for press and advertising services for GEECF. Digital Wall Street,
Inc. has received three thousand seven hundred fifty dollars from AEMD for the
press and advertising services.  For a complete list of our business
relationships, visit http://www.wallst.net/disclaimer.asp.

   Contact
   Nick Iyer
   Digital Wall Street, Inc.
   800 4 WALL ST


DATASOURCE: Wall Street Network



CONTACT: Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST



Web site:  http://wallst.net/superstock/CBAI/cbai.html

http://www.wallst.net/ 

Copyright